Neuzurin®

Across ADHD, Parkinson's, Alzheimer's, and Autism Spectrum Disorder, clinical manifestations arise from a combination of specific neurotransmitter imbalances, shared secondary drivers (neuroinflammation, oxidative stress, mitochondrial impairment, and synaptic degradation). Neuzurin is a blend of botanicals targeting dopamine, acetylcholine, glutamate, and GABA signaling, thus, delivering crucial symptomatic relief. In order to halt disease progression in Alzheimer's and Parkinson's, phytochemicals of Neuzurin prevent protein misfolding (Aβ, tau, α-synuclein). Furthermore, loss of neurons in neurodegenerative conditions are optimally managed or reversed by agonistic actions of the botanicals on tropomyosin receptor kinase B (TrkB-FL). Our Neuzurin is a key therapeutic option for neurological issues with realistic goals of symptomatic relief and neurotrophic support of synaptic plasticity, where patients can experience slow or reversed functional decline, and optimize patient outcomes.